In contrast, recent data from the New York University Women's Health Study suggested that, among young women, high levels of functional IGFBP-3 could be associated with a reduction of breast cancer risk whereas high levels of total IGFBP-3 could be associated with an increased risk of breast cancer [15]. The gene discussed is IGFBP3; the disease is breast carcinoma.